Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2025-12-24 @ 3:30 PM
NCT ID:
NCT05028192
Eligibility Criteria:
Inclusion Criteria:
* Patients with confirmed histopathological diagnosis of rectal adenocarcinoma ycTNM stage II, III, or IV (AJCC 8th).
* Patients treated with neoadjuvant therapy.
* Patients that will be subject to curative intent or palliative surgery through any approach (open, laparoscopic, or robotic).
* Ability to sign the informed consent.
Exclusion Criteria:
* Rectal cancer stage I or any stage without neoadjuvant therapy.
* Age \< 18 and \>75 years
* Long steroid treatment for any cause.
* Emergency setting.
* Co-existent inflammatory bowel disease.
* Inflammatory comorbidities (liver failure, diabetes, metabolic acidosis, acute and chronic renal failure, sepsis, AIDS, acute and chronic hepatitis, autoimmune disorders, and chronic obstructive pulmonary disease).
* Healthy volunteers.
* Other (simultaneous) neoplastic disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05028192
Study Brief:
Protocol Section:
NCT05028192